Direkt zum Inhalt
Merck

YSC1

Sigma-Aldrich

Yeast from Saccharomyces cerevisiae

Type I

Synonym(e):

(Bakers yeast)

Anmeldenzur Ansicht organisationsspezifischer und vertraglich vereinbarter Preise


About This Item

UNSPSC-Code:
12352202
NACRES:
NA.81

Biologische Quelle

Saccharomyces cerevisiae

Typ

Type I

Form

powder or solid

Anwendung(en)

food and beverages
microbiology

Lagertemp.

2-8°C

Allgemeine Beschreibung

Yeast from Saccharomyces cerevisiae (Baker′s yeast) is the oldest microbial starter. It is a facultative anaerobe.

Anwendung

Yeast from Saccharomyces cerevisiae has been used:
  • as a biocatalyst for the anode of yeast microbial fuel cell
  • for the production of ethanol for fuel use
  • to prepare yeast extract

Biochem./physiol. Wirkung

Yeast from Saccharomyces cerevisiae (Baker′s yeast) is used as a protein supplement, energy booster and immune enhancer. It serves as a dough leavening agent in bread production by converting the fermentable sugars to CO2 and ethanol. Baker′s yeast exhibits aroma, anti-molding and nutritive properties. It acts as a cell factory.

Vorsicht

Autolyzes in aqueous buffer at 37 °C.

Angaben zur Herstellung

Dried to avoid inactivation of enzymes.

Lagerklassenschlüssel

11 - Combustible Solids

WGK

WGK 3

Flammpunkt (°F)

Not applicable

Flammpunkt (°C)

Not applicable

Persönliche Schutzausrüstung

Eyeshields, Gloves, type N95 (US)


Analysenzertifikate (COA)

Suchen Sie nach Analysenzertifikate (COA), indem Sie die Lot-/Chargennummer des Produkts eingeben. Lot- und Chargennummern sind auf dem Produktetikett hinter den Wörtern ‘Lot’ oder ‘Batch’ (Lot oder Charge) zu finden.

Besitzen Sie dieses Produkt bereits?

In der Dokumentenbibliothek finden Sie die Dokumentation zu den Produkten, die Sie kürzlich erworben haben.

Die Dokumentenbibliothek aufrufen

Enhanced ethanol production via electrostatically accelerated fermentation of glucose using Saccharomyces cerevisiae
Mathew AS, et al.
Scientific Reports, 5, 15713-15713 (2015)
A microbial biofuel cell with an air-breathing cathode for in vivo glucose sensing applications
Lee JW
Analytical Methods : Advancing Methods and Applications, 7(8), 3324-3326 (2015)
Rebeccah J Katzenberger et al.
G3 (Bethesda, Md.), 6(12), 4151-4166 (2016-10-19)
Outcomes of traumatic brain injury (TBI) vary because of differences in primary and secondary injuries. Primary injuries occur at the time of a traumatic event, whereas secondary injuries occur later as a result of cellular and molecular events activated in
Zachariah P G Olufs et al.
Scientific reports, 8(1), 2348-2348 (2018-02-07)
Genetic variability affects the response to numerous xenobiotics but its role in the clinically-observed irregular responses to general anesthetics remains uncertain. To investigate the pharmacogenetics of volatile general anesthetics (VGAs), we developed a Serial Anesthesia Array apparatus to expose multiple
Engineering baker?s yeast: room for improvement
Randez-Gil F, et al.
Trends in biotechnology, 17(6), 237-244 (1999)

Protokolle

This procedure may be used for the determination of Lyticase activity using Baker’s yeast as the substrate.

Unser Team von Wissenschaftlern verfügt über Erfahrung in allen Forschungsbereichen einschließlich Life Science, Materialwissenschaften, chemischer Synthese, Chromatographie, Analytik und vielen mehr..

Setzen Sie sich mit dem technischen Dienst in Verbindung.